Publication:
Cultural adaptation and validation of a peninsular Spanish version of the MSTCQ(C) Multiple sclerosis; (Multiple Sclerosis Treatment Concerns Questionnaire)

No Thumbnail Available

Date

2017-01-01

Authors

Munteis Olivas, E.
Navarro Mascarell, G.
Meca Lallana, J.
Maestre Martinez, A.
Perez Sempere, A.
Gracia Gil, J.
Pato Pato, A.

Advisors

Journal Title

Journal ISSN

Volume Title

Publisher

Elsevier doyma sl
Metrics
Google Scholar
Export

Research Projects

Organizational Units

Journal Issue

Abstract

Introduction: Although subcutaneous treatments for multiple sclerosis (MS) have been shown to be effective, adverse reactions and pain may adversely affect treatment satisfaction and adherence. This study presents an adapted and validated Spanish version of the Multiple Sclerosis Treatment Concerns Questionnaire (c) (MSTCQ), which evaluates satisfaction with the injection device (ID) across 4 domains: injection system (A), side effects (B) (flu-like symptoms, reactions, and satisfaction), experience with treatment (C) and benefits (D). Methods: Two study phases: 1) Cultural adaptation process with input from experts (n = 6) and patients (n = 30). 2) Validation obtained by means of an observational, cross-sectional, multi centre study evaluating 143 adult MS patients using an ID. Tools employed: MSTCQ, Patient Reported Indices for Multiple Sclerosis (PRIMUS), and Treatment Satisfaction Questionnaire for Medication (TSQM (c)). Psychometric properties: Feasibility (percentage of valid cases and floor/ceiling effects); Reliability (Cronbach alpha) and test-retest correlation (n =41, intractass correlation coefficient, ICC); and construct validity (factor analysis of domains A and B) and convergent validity (Spearman rank-order correlation for MSTCQ (c) vs TSQM (c)). Results: Mean age (SD) was 41.94 (10.47) years, 63% of the group were women, and 88.11% presented relapsing-remitting MS. Mean (SD) EDSS score was 2.68 (1.82) points. MSTCQ (c) completion was high (0%-2.80% missing data). Internal consistency was high at alpha = 0.89 for the total score (A+ B) and alpha = 0.76, 0.89, and 0.92 for domains A, B, and C, respectively. The version demonstrated excellent test-retest reliability for the total (ICC = 0.98) and for domains A, B, and C: ICC =0.82, 0.97, and 0.89, respectively. Factor analysis corroborated the internal structure of the original questionnaire. The association between total and domain scores on both the MSTCQ (c) and the TSQM (c) was moderately strong (Rho = 0.42-0.74) and significant (P

Description

MeSH Terms

DeCS Terms

CIE Terms

Keywords

Multiple sclerosis, Patient satisfaction, Injection system, Questionnaire, Reactions, Validation, Interferon beta-1b, Satisfaction, Multicenter, Perceptions, Adherence, Disease, Device

Citation